ADVERTISEMENT

Gilead Sciences

Gilead's remdesivir reduces Covid mortality risk: Data

The data was presented at the World Microbe Forum (WMF) this week

21 June 2021, 13:43 IST

Gilead's remdesivir reduces Covid mortality risk: Data

Gilead's remdesivir reduces Covid mortality risk: Data

Gilead's remdesivir reduces Covid mortality risk: Data

21 June 2021, 13:43 IST

Gilead's profit rises despite lower HIV drug sales

The 16% rise in revenue for the quarter to $6.4 billion was still short of Wall Street's estimates of $6.73 billion

29 April 2021, 23:50 IST

Gilead's profit rises despite lower HIV drug sales

Gilead's profit rises despite lower HIV drug sales

Gilead's profit rises despite lower HIV drug sales

29 April 2021, 23:50 IST

Gilead to expand availability of Remdesivir in India

Remdesivir is approved in Indiafor the treatment of suspected or laboratory-confirmed Covid-19 in adults and children hospitalised with severe disease

27 April 2021, 07:49 IST

Gilead to expand availability of Remdesivir in India

Gilead to expand availability of Remdesivir in India

Gilead to expand availability of Remdesivir in India

27 April 2021, 07:49 IST

Covid-19 leads to decrease in HIV tests

About 50% of prescribers also reported a decline in prescribing refill antiretroviral medication to PLHIV

01 December 2020, 10:19 IST

Covid-19 leads to decrease in HIV tests

Covid-19 leads to decrease in HIV tests

Covid-19 leads to decrease in HIV tests

01 December 2020, 10:19 IST

WHO advises against remdesivir for Covid-19 patients

The antiviral is one of only two medicines currently authorised to treat Covid-19 patients across the world

20 November 2020, 09:00 IST

WHO advises against Gilead's remdesivir for all hospitalised Covid-19 patients

WHO advises against Gilead's remdesivir for all hospitalised Covid-19 patients

WHO advises against remdesivir for Covid-19 patients

20 November 2020, 09:00 IST

Covid: Top intensive care body against remdesivir use

13 November 2020, 12:56 IST

World's top intensive care body advises against remdesivir for sickest Covid-19 patients

World's top intensive care body advises against remdesivir for sickest Covid-19 patients

Covid: Top intensive care body against remdesivir use

13 November 2020, 12:56 IST

Russian firm seeks to produce Covid drug without patent

Pharmasyntez previously approached Gilead requesting a voluntary licence to produce and distribute the drug in Russia

02 November 2020, 09:26 IST

Russian firm seeks to produce Covid-19 drug without patent

Russian firm seeks to produce Covid-19 drug without patent

Russian firm seeks to produce Covid drug without patent

02 November 2020, 09:26 IST

'Nations must consider all Gilead Covid drug trials'

23 October 2020, 20:00 IST

Nations mulling Gilead's Covid-19 drug, redesivir, should consider trial flop, too, says WHO

Nations mulling Gilead's Covid-19 drug, redesivir, should consider trial flop, too, says WHO

'Nations must consider all Gilead Covid drug trials'

23 October 2020, 20:00 IST

Remdesivir cuts 5 days off Covid-19 recovery time

Gilead's drug was among the first to be used as a treatment for the novel coronavirus, and was one of the drugs recently used to treat Trump

09 October 2020, 10:16 IST

Remdesivir shaved 5 days off Covid-19 recovery time, reduced risk of death in some

Remdesivir shaved 5 days off Covid-19 recovery time, reduced risk of death in some

Remdesivir cuts 5 days off Covid-19 recovery time

09 October 2020, 10:16 IST

Takeda's Covid plasma treatment enters clinical trial

09 October 2020, 06:22 IST

Takeda-led Covid-19 plasma treatment enters clinical trial with first patient

Takeda-led Covid-19 plasma treatment enters clinical trial with first patient

Takeda's Covid plasma treatment enters clinical trial

09 October 2020, 06:22 IST